|
Q1 FY2027
As of Sep 30, 2026
|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash in bank | |||||
| Deferred offering costs | |||||
| Total Current Asset | |||||
| Cash and marketable securities held in the trust | |||||
| Total Assets | |||||
| Liabilities | |||||
| Promissory Note Related Party | |||||
| Accrued expenses | |||||
| Promissory note - related party | |||||
| Total Current Liabilities | |||||
| Deferred Underwriting Commission | |||||
| Total Liabilities | |||||
| Class A ordinary shares, $0.0001 par value, 450,000,000 shares authorized, 5,750,000 shares subject to possible redemption as of September 30, 2026 and June 30, 2026 | |||||
| Shareholders’ Equity | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Retained earnings | |||||
| Total Shareholders’ Equity | |||||
| Total Liabilities and Shareholders’ Equity |
Loading...